Important worth mentioning that reports on the role of MTHFR polymorphism in GBM were often case-control studies, mainly investigating the influence of genotypic variants on disease risk [47–49], which clearly was not the scope of the present study. The gene discussed is MTHFR; the disease is glioblastoma.